Russia flies planeload of Sputnik V vaccine to Argentina and Bolivia | Inquirer News

Russia flies planeload of Sputnik V vaccine to Argentina and Bolivia

/ 07:30 AM January 29, 2021

Russia flies planeload of Sputnik V vaccine to Argentina and Bolivia

A shipment of doses of the Sputnik V (Gam-COVID-Vac) vaccine against the coronavirus disease (COVID-19) is transported after arriving at the Ezeiza International Airport, in Buenos Aires, Argentina January 28, 2021. REUTERS/Agustin Marcarian

BUENOS AIRES Russia has dispatched 240,000 doses of its Sputnik V coronavirus vaccine on Thursday, for use mostly in Argentina and the rest bound for Bolivia, airline and Argentine health officials said.

Bolivia, which an airline official said will take delivery of 20,000 doses from the consignment, will be the second Latin American country after Argentina to rollout the Russian vaccine.

Article continues after this advertisement

Argentina has already taken delivery of two consignments, each with 300,000 shots.

FEATURED STORIES

Aerolineas Argentinas said in a tweet just after midday local time that a total of 240,000 doses had arrived in Buenos Aires. “Unloading has begun, the doses will be stored in the Airbus warehouse, packed in Thermobox (refrigerated boxes).”

An AA spokesman told Reuters earlier that the latest consignment of 220,000 doses for Argentina was equally split between first and second shots of the two-stage vaccine.

Article continues after this advertisement

The Argentine deliveries fall short of the 5 million doses the health authorities had said they expected to receive in January from Russia.

Article continues after this advertisement

From Buenos Aires, Bolivia’s BOA national airline was scheduled to pick up its share of the shipment to fly to La Paz.

Article continues after this advertisement

The Russian Direct Investment Fund (RDIF), which markets Sputnik V, and the Gamaleya Research Institute, which developed it, said on Wednesday supplies to Latin America might be delayed by up to three weeks as production capacity was ramped up.

RDIF declined to comment on the latest shipment.

Article continues after this advertisement

Argentina had not received advanced notice of the size of the latest shipment of 220,000 doses before it was sent, health ministry official Carla Vizzotti told state news agency Telam.

“We are super careful until we have confirmation, due to the particular dynamic of the world supply of vaccines,” she said, adding she hoped more would arrive “during the next few days and weeks.”

Argentina has administered 272,323 people with the first dose of the Sputnik V vaccine and 45,710 people with the second dose, ministry figures show. Argentina has also approved the vaccine manufactured by AstraZeneca.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Bolivia’s President Luis Arce wrote on Twitter that the 20,000 doses his country was receiving were more than the 6,000 originally agreed for delivery in January. He said the vaccines would be administered to frontline health workers.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: Argentina, Bolivia, Coronavirus, COVID-19, Health, pandemic, Russsia, SARS-CoV-2, Sputnik V, vaccine, Virus

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.